Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study

Department of Cardiology, Tel-Aviv Medical Center, Israel.

The growing recognition of the importance of early thrombolysis in evolving myocardial infarction was the basis for the present study, which evaluated the effectiveness, feasibility and safety of prehospital thrombolytic therapy. In a relatively small study, 118 patients were allocated to receive either prehospital treatment with recombinant tissue-type plasminogen activator (rt-PA) in the mobile intensive care unit (group A, 74 patients) or hospital treatment (group B, 44 patients). A total of 120 mg of rt-PA was infused over a period of 6 h. All patients were fully heparinized and underwent radionuclide left ventriculography and coronary angiography during hospitalization. Although group A was treated significantly earlier than group B after onset of symptoms (94 +/- 36 versus 137 +/- 45 min, respectively; p less than 0.001), no significant differences were observed between the groups in 1) extent of myocardial necrosis, 2) global left ventricular ejection fraction at discharge, 3) patency of infarct-related artery, 4) length of hospital stay, and 5) mortality at 60 days. However, a trend to a lower incidence of congestive heart failure at hospital discharge was observed in the prehospital-treated compared with the hospital-treated group (7% versus 16%, respectively; p = NS). No major complications occurred during transportation. It is concluded that myocardial infarction can be accurately diagnosed and thrombolytic therapy initiated relatively safely during the prehospital phase by the mobile intensive care team, thus instituting a beneficial clinical trend in favor of prehospital thrombolysis.

This article has been cited by other articles:

				R. E. O'Connor, L. Bossaert, H.-R. Arntz, S. C. Brooks, D. Diercks, G. Feitosa-Filho, J. P. Nolan, T. L. V. Hoek, D. L. Walters, A. Wong, et al. Part 9: Acute Coronary Syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Circulation, October 19, 2010; 122(16_suppl_2): S422 - S465. [Full Text] [PDF]

				S. G. Goodman, V. Menon, C. P. Cannon, G. Steg, E. M. Ohman, and R. A. Harrington Acute ST-Segment Elevation Myocardial Infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 708S - 775S. [Abstract] [Full Text] [PDF]

				Part 5: Acute Coronary Syndromes Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72. [Full Text] [PDF]

				M S V M Chittari, I Ahmad, B Chambers, F Knight, A Scriven, and D Pitcher Retrospective observational case-control study comparing prehospital thrombolytic therapy for ST-elevation myocardial infarction with in-hospital thrombolytic therapy for patients from same area Emerg. Med. J., August 1, 2005; 22(8): 582 - 585. [Abstract] [Full Text] [PDF]

				C. J. Terkelsen, J. F. Lassen, B. L. Norgaard, J. C. Gerdes, S. H. Poulsen, K. Bendix, J. P. Ankersen, L. B.-H. Gotzsche, F. K. Romer, T. T. Nielsen, et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention Eur. Heart J., April 2, 2005; 26(8): 770 - 777. [Abstract] [Full Text] [PDF]

				D. A. Morrow, E. M. Antman, A. Sayah, K. C. Schuhwerk, R. P. Giugliano, J. A. deLemos, M. Waller, S. A. Cohen, D. G. Rosenberg, S. S. Cutler, et al. Evaluation of the time saved byprehospital initiation of reteplase forST-elevation myocardial infarction: Results of the early retavase-thrombolysisin myocardial infarction (ER-TIMI) 19 trial J. Am. Coll. Cardiol., July 3, 2002; 40(1): 71 - 77. [Abstract] [Full Text] [PDF]

				L. J. Morrison, P. R. Verbeek, A. C. McDonald, B. V. Sawadsky, and D. J. Cook Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction: A Meta-analysis JAMA, May 24, 2000; 283(20): 2686 - 2692. [Abstract] [Full Text] [PDF]

				G. A. Ewy and J. P. Ornato Emergency cardiac care: introduction J. Am. Coll. Cardiol., March 15, 2000; 35(4): 825 - 880. [Full Text] [PDF]

				M W Millar-Craig, A V Joy, M Adamowicz, R Furber, and B Thomas Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission Heart, November 1, 1997; 78(5): 456 - 461. [Abstract] [Full Text] [PDF]

				Y. Adler, Y. Finkelstein, G. Zandeman-Goddard, M. Blank, M. Lorber, A. Lorber, D. Faden, and Y. Shoenfeld The presence of antiphospholipid antibodies in acute myocardial infarction Lupus, August 1, 1995; 4(4): 309 - 313. [Abstract] [PDF]

				W. D. Weaver, M. Cerqueira, A. P. Hallstrom, P. E. Litwin, J. S. Martin, P. J. Kudenchuk, M. Eisenberg, and the Myocardial Infarction Triage and Intervention Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy: The Myocardial Infarction Triage and Intervention Trial JAMA, September 8, 1993; 270(10): 1211 - 1216. [Abstract] [PDF]

				COMING SOON: PRE-HOSPITAL THROMBOLYSIS TRIALS Journal Watch (General), April 17, 1990; 1990(417): 1 - 1. [Full Text]